Quest Diagnostics outperformed its rival Thermo Fisher Scientific Inc. in a recent market comparison.
1 report, 0 independent
Updated Jun 23
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Quest Diagnostics outperformed its rival Thermo Fisher Scientific Inc. in a recent market comparison.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Quest Diagnostics
medical research company
-
Thermo Fisher Scientific Inc.
multinational company providing scientific instrumentation
Nothing else this week.
Related events
- Thermo Fisher Scientific Inc. and iSpecimen are two healthcare companies that are currently competing for market share.
- Thermo Fisher Scientific Inc. filed required reports with the SEC on June 16, 2026, influenced by analyst reports from Morgan Stanley.
- Quest Diagnostics acquired clinical testing assets from Fresenius Medical Care to provide dialysis-related lab services.
Coverage
Newest first; wire copies grouped- Unknown outlet